1,218 followers
Just published: A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan Full article here: https://t.co/5Z31cZ4Sft #AlzheimersDisease #dementia https://t.co/OR0Ev